Piozena Plus Tablet 15 mg+850 mg combines Pioglitazone 15 mg and Metformin Hydrochloride 850 mg in a single oral tablet, providing effective dual-action therapy for type 2 diabetes mellitus. This combination is designed for patients whose blood glucose is not adequately controlled with diet, exercise, or monotherapy with either Pioglitazone or Metformin. By targeting multiple mechanisms of glucose regulation, Piozena Plus 15 mg+850 mg offers improved glycemic control and helps prevent long-term complications associated with diabetes.

Pioglitazone works by improving insulin sensitivity in peripheral tissues such as muscle and adipose tissue, allowing more efficient glucose utilization. Metformin primarily decreases hepatic glucose production and enhances peripheral glucose uptake. Together, they address the key pathophysiological defects in type 2 diabetes—insulin resistance and excessive hepatic glucose output—providing a comprehensive approach to blood sugar management.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Piozena Plus Tablet 15 mg+850 mg is indicated for:

• Management of type 2 diabetes mellitus in adults not adequately controlled with lifestyle modifications alone

• Combination therapy for patients not achieving target blood sugar levels with either Pioglitazone or Metformin monotherapy

• Adjunct therapy alongside diet and exercise for improved glycemic control

• Patients requiring dual-action therapy that targets insulin resistance and hepatic glucose production

This combination reduces pill burden and improves patient adherence by providing both agents in a single tablet.

Dosage and Administration

• The usual dose is 1 tablet once or twice daily, taken with meals to minimize gastrointestinal side effects caused by Metformin.

• Dose adjustments should be based on blood glucose levels, renal function, and tolerance under medical supervision.

• Monitor fasting and postprandial blood sugar regularly to assess treatment efficacy.

• Metformin is contraindicated in patients with significant renal impairment, so kidney function should be checked before starting therapy.

• Tablets should be swallowed whole with water and should not be crushed or chewed.

Benefits of Piozena Plus Tablet 15 mg+850 mg

• Provides dual-action control of blood sugar through insulin sensitization and reduced hepatic glucose production

• Helps lower both fasting and postprandial glucose levels

• Convenient combination tablet reduces the number of pills taken daily

• Enhances glycemic control for patients inadequately managed with monotherapy

• May contribute to improved lipid profiles and reduce risk of diabetes-related complications when combined with lifestyle management

Possible Side Effects

Common side effects include:

• Gastrointestinal disturbances such as nausea, diarrhea, or abdominal discomfort (primarily due to Metformin)

• Mild fluid retention or weight gain (primarily due to Pioglitazone)

• Headache or dizziness

• Rare liver enzyme elevations or hepatotoxicity

Serious but uncommon side effects include:

• Exacerbation of heart failure in patients with pre-existing cardiovascular conditions

• Lactic acidosis, a rare but serious complication associated with Metformin

• Increased risk of bladder cancer with long-term Pioglitazone use

Patients should seek immediate medical attention if severe or persistent symptoms occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Not suitable for type 1 diabetes or diabetic ketoacidosis

• Avoid in patients with renal or hepatic impairment

• Use cautiously in patients with heart failure or cardiovascular disease

• Regular monitoring of blood sugar, liver function, kidney function, and cardiovascular health is recommended

• Pregnant or breastfeeding women should use this medication only under medical supervision

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiration date.

Piozena Plus Tablet 15 mg+850 mg offers a convenient, effective dual therapy option for type 2 diabetes, improving insulin sensitivity and controlling hepatic glucose production to maintain long-term glycemic stability.